What this means in practice
Nothing supports paying for both. If someone wants to take one, the choice between them turns on regulatory status and trial record rather than on any measured difference in how much NAD they produce, which came out comparable. Neither has been shown to change a health outcome in a healthy person.
What people say
Stack them. NMN and NR hit different points in the NAD pathway, so taking both covers more bases than either alone and gets your levels up faster. NMN is one step closer to NAD, and NR is small enough to get into cells, so together you get the best of both.
What the evidence supports
A 2026 randomised study in 65 healthy adults gave NMN, nicotinamide riboside and plain nicotinamide separately for 14 days. NMN and nicotinamide riboside raised circulating NAD comparably; plain nicotinamide did not. Tested directly in whole blood, none of the three was a potent NAD booster, while nicotinic acid was. Work with human gut microbiota outside the body showed that both NMN and nicotinamide riboside give rise to nicotinic acid. The authors propose that both act through that shared microbial step. No trial in this base has given the two together, so redundancy is an inference from a shared mechanism rather than a measured result.
How it is supposed to work
Both are proposed to be broken down by gut bacteria into nicotinic acid, which is then what raises circulating NAD through the Preiss-Handler pathway. If that is how both work, they are two routes to the same intermediate rather than two independent inputs.
Which way it runs
Symmetrical. Neither compound has been shown to add anything to the other in either order, and the case for stacking them is the same weak case in both directions.
What is still missing
The stacking pitch depends on the two compounds entering the pathway at different points, and the best current human mechanism has them converging on the same one before either reaches the bloodstream.
Sources
- The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humansChristen S, Redeuil K, Goulet L, et al. (Cuenoud B), 2026
- Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight AdultsConze D, Brenner C, Kruger CL, 2019
- The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trialYi L, Maier AB, Tao R, et al., 2023
- The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-AnalysisProkopidis K, Moriarty F, Bahat G, McLean J, Church DD, Patel HP, 2025